Literature DB >> 9835258

Does radiofrequency ablation induce a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study.

S Dorbala1, A J Cohen, L A Hutchinson, E Menchavez-Tan, J S Steinberg.   

Abstract

INTRODUCTION: Although thromboembolism is an uncommon complication of radiofrequency (RF) ablation, some preliminary reports have suggested that RF ablation results in activation of the coagulation system, possibly increasing this risk. We hypothesized that the insertion of intravenous catheters and their prolonged intravenous placement rather than RF ablation activates the coagulation cascade. METHODS AND
RESULTS: Thirty-seven patients, group 1 (n = 21) during RF ablation, and group 2 (n = 16) during routine electrophysiologic studies (EPS), were studied prospectively. Blood was drawn for coagulation and fibrinolytic studies following insertion of venous sheaths (T0), following catheter placement (T1), and 1 hour after completion of RF ablation or EPS (T2). Conversion of prothrombin to thrombin was measured using thrombin-antithrombin complex (TAT) and prothrombin activation peptide (F1+2), and fibrinolytic activity was assessed using D-dimer concentration. Levels of D-dimer increased in group 1 from 823.52+/-323.52 ng/mL at T0 to 1,314.28+/-297.63 ng/mL at T2 (P = 0.005), and in group 2 from 658.15+/-161.70 ng/mL at T0 to 1625+/-641.45 ng/mL at T2 (P = 0.064). TAT levels increased from to 27.74+/-5.6 microg/L at T0 to 52.99+/-5.93 microg/L at T2 in group 1 (P = 0.09), and from 19.79+/-5.14 microg/L at T0 to 73.5+/-24.15 microg/L at T2 in group 2 (P = 0.05). F1+2 concentration increased from 1.52+/-0.30 nmol/L at T0 to 3.06+/-0.41 nmol/L at T2 in group 1 (P = 0.004), and from 1.32+/-0.30 nmol/L at T0 to 3.11+/-0.46 nmol/L at T2 in group 2 (P = 0.087). There was no significant difference in the concentration of the three coagulation variables between group 1 and group 2 at any given time point. No correlation was demonstrable between concentration of D-dimers, TAT, or F1+2 and variables of RF delivery such as cumulative energy, number of RF energy applications, or number of impedance rises. However, a significant positive correlation (r = 0.65, P<0.01) was noted between the duration of the RF ablation procedure and the concentration of D-dimers.
CONCLUSION: We conclude that activation of the coagulation cascade in RF ablation procedures is not related to the delivery of RF energy, but is related to the placement of intravascular catheters and to the duration of the ablation procedure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835258     DOI: 10.1111/j.1540-8167.1998.tb00086.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  12 in total

Review 1.  Practical issues in the management of novel oral anticoagulants-cardioversion and ablation.

Authors:  Abhishek Maan; E Kevin Heist; Jeremy N Ruskin; Moussa Mansour
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

Review 2.  Cerebral Embolization During AF Ablation -Pathophysiology, Prevention and Management.

Authors:  Nasir Shariff; Nagesh Antha; Manish Roy; Hari Joshi; Vadim Levin
Journal:  J Atr Fibrillation       Date:  2013-04-06

3.  Hemostatic changes before and during electrophysiologic study and radiofrequency catheter ablation.

Authors:  Petr Parizek; L Haman; M Pleskot; M Pecka; J Bukac; P Stransky; J Maly
Journal:  Int J Hematol       Date:  2011-03-09       Impact factor: 2.490

4.  Radiofrequency ablation reduces expression of SELF by upregulating the expression of microRNA-26a/b in the treatment of atrial fibrillation.

Authors:  Min Dai; Tao Jiang; Cai-Dong Luo; Wei Du; Min Wang; Qing-Yan Qiu; Hu Wang
Journal:  J Interv Card Electrophysiol       Date:  2022-07-21       Impact factor: 1.759

5.  Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.

Authors:  Alan Bulava; Ludek Slavík; Martin Fiala; Petr Heinc; Marcela Skvarilova; Jan Lukl; Vera Krcová; Karel Indrák
Journal:  J Interv Card Electrophysiol       Date:  2004-06       Impact factor: 1.900

6.  Periprocedural management of anticoagulation and antiplatelet therapies in patients undergoing electrophysiologic procedures.

Authors:  Jordana Kron; Daniel Alexander; Mark A Wood
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10

7.  Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Mohamed Bassiouny; Walid Saliba; John Rickard; Mingyuan Shao; Albert Sey; Mariam Diab; David O Martin; Ayman Hussein; Maurice Khoury; Bernard Abi-Saleh; Samir Alam; Jay Sengupta; P Peter Borek; Bryan Baranowski; Mark Niebauer; Thomas Callahan; Niraj Varma; Mina Chung; Patrick J Tchou; Mohamed Kanj; Thomas Dresing; Bruce D Lindsay; Oussama Wazni
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-04-03

8.  Optimal strategies including use of newer anticoagulants for prevention of stroke and bleeding complications before, during, and after catheter ablation of atrial fibrillation and atrial flutter.

Authors:  Prashant D Bhave; Bradley P Knight
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08

Review 9.  Apixaban for periprocedural anticoagulation during catheter ablation of atrial fibrillation: a systematic review and meta-analysis of 1691 patients.

Authors:  Alessandro Blandino; Francesca Bianchi; Giuseppe Biondi-Zoccai; Stefano Grossi; Maria Rosa Conte; Francesco Rametta; Fiorenzo Gaita
Journal:  J Interv Card Electrophysiol       Date:  2016-05-23       Impact factor: 1.900

10.  Prevention and Treatment of Lower Limb Deep Vein Thrombosis after Radiofrequency Catheter Ablation: Results of a Prospective active controlled Study.

Authors:  Lan Li; Bao-Jian Zhang; Bao-Ku Zhang; Jun Ma; Xu-Zheng Liu; Shu-Bin Jiang
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.